Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Differentiation Therapy
100%
Molecular Mechanism
100%
All-trans Retinoic Acid
100%
Acute Promyelocytic Leukemia
100%
Leukemia Therapy
100%
Novel Treatments
100%
Retinoic Acid Resistance
100%
Leukemia Patients
21%
Arsenic Trioxide
14%
Clinical Remission
14%
Acute Myeloid Leukemia
7%
Leukemic Cells
7%
Patient Survival
7%
Granulocytes
7%
Bone Marrow
7%
Remission
7%
Acid Activation
7%
Conventional Chemotherapy
7%
Hypoplasia
7%
Point mutation
7%
Clinical Efficacy
7%
Metabolism
7%
Terminal Differentiation
7%
Chemotherapy Alone
7%
Ligand-binding Domain
7%
Cell Resistance
7%
Retinoic Acid Receptor
7%
Acid Treatment
7%
Highly Effective
7%
Anthracycline-based Chemotherapy
7%
Molecular Events
7%
Vitamins
7%
Clinical Observation
7%
Retinol
7%
Promyelocytic Leukemia
7%
Clinical Approach
7%
Hemorrhagic Disease
7%
Biochemical Metabolites
7%
Promyelocyte
7%
Plasma Drug Levels
7%
Myeloid Cell Differentiation
7%
Pharmacology, Toxicology and Pharmaceutical Science
Retinoic Acid
100%
Promyelocytic Leukemia
100%
Remission
27%
Chemotherapy Regimen
27%
Retinol
18%
Malignant Neoplasm
9%
Acute Myeloid Leukemia
9%
Arsenous Acid
9%
Arsenite
9%
Syndrome
9%
Anthracycline
9%
Bioavailability
9%
Bone Marrow Hypoplasia
9%
Retinoic Acid Receptor Alpha
9%